Innovent presents mazdutide Phase 3 clinical study results at ADA 85th Scientific Sessions

Harbour BioMed and Otsuka collaborate on advancing BCMAxCD3 bispecific T-cell engagers

Galderma's nemolizumab recommended for NHS funding in England and Wales for atopic dermatitis

Sanofi's rilzabrutinib granted US orphan drug designation for sickle cell disease

RemeGen secures approval in China for Telitacicept in treating generalised myasthenia gravis

Sanofi acquires DR-0201 from Dren Bio to expand immunology pipeline

Celltrion announces FDA interchangeability designation for all YUFLYMA's approved dosage forms and strengths

InnoCare reports first patient dosed in Phase II/III vitiligo trial

First participant dosed in second head-to-head Phase 3 study of mazdutide versus semaglutide in China

AB Science reports masitinib shows neuroprotective potential in preclinical model of neurodegeneration

Hemogenyx Pharmaceuticals expands HG-CT-1 trial to include paediatric AML patients

CARsgen reports positive preliminary clinical data for CT0596 in R/R MM

RTW Biotech portfolio company Jade Biosciences merges with Aerovate Therapeutics

Diamyd Medical to receive European patent for insulin antigen treatment targeting autoimmune diabetes

Innovent's limertinib receives Chinese regulatory approval for first-line treatment of lung cancer